Abstracts tagged "osteoporosis"

Abstract Number: 1558 • ACR Convergence 2020
Cinematic Rendering Enables Depiction of Bone Anabolic Effects in Patients Treated with Baricitinib
Sara Bayat¹, David Simon², Louis Schuster², Georg Schett³ and Arnd Kleyer², ¹Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, ²Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, ³Friedrich-Alexander-Universität Erlangen- Nuremberg, Erlangen, Germany
Background/Purpose: Preclinical studies show that tsDMARDs such as baricitinib may be a therapeutic agent for bone anabolic effects by increasing osteoblast function in inflammatory conditions.[1]…
Abstract Number: 0111 • ACR Convergence 2020
Assessment and Treatment of Glucocorticoid-Induced Osteoporosis in a Rheumatology Clinic
Amanda Stefl¹, Shikha Singla², Jessica Michaud¹, Kama Thomas², Lisa Rein² and Mary Ellen Csuka², ¹Froedtert Hospital, Milwaukee, WI, ²Medical College of Wisconsin, Milwaukee, WI
Background/Purpose: Glucocorticoids (GC) are used as a long-term treatment option for an estimated 1% of the US population. The American College of Rheumatology has maintained…
Abstract Number: 0130 • ACR Convergence 2020
The Prevalence of Osteoporosis in Individuals with Osteoarthritis: A Systematic Review
Timothy Varghese¹, Ali Ahmadi Pirshahid², Dongkeun Kim² and Yueyang Li², ¹Schulich School of Medicine & Dentistry, Richmond Hill, ON, Canada, ²Schulich School of Medicine & Dentistry, London, ON, Canada
Background/Purpose: There is controversy regarding the relationship between osteoarthritis (OA) and osteoporosis (OP). While OA may be associated with increased bone mineral density (BMD) due…
Abstract Number: 1588 • ACR Convergence 2020
A Quality Improvement Project to Improve Bone Densitometry Ordering in Adult Patients on Chronic Glucocorticoids
Katherine Kaufman¹, Philip Chu¹, Mithu Maheswaranathan¹, Andrew Johannemann¹, D Ryan Anderson¹, Isaac Smith¹, Akrithi Udupa¹, Mary Buckley¹, Laura Cannon¹, Rachel Randell¹ and David Leverenz¹, ¹Duke University, DURHAM, NC
Background/Purpose: The 2017 ACR guideline for glucocorticoid-induced osteoporosis (GIOP) recommends DXA testing in patients aged ≥40 years on chronic glucocorticoids. We performed a quality improvement…
Abstract Number: 270 • 2019 ACR/ARP Annual Meeting
Outcomes of a Fracture Liaison Service at an Academic Health Center
Micah Yu¹, Donna Jose ², Parke Hudson ², Christina Downey, MD ³, Wesley Phipatanakul ², Silvana Giannelli ², Kevin Codorniz ⁴ and Karina Torralba ⁵, ¹Loma Linda University Medical Center, loma linda, ²Loma Linda University, Loma Linda, ³Loma Linda University Medical Center, Loma LInda, CA, ⁴[email protected], Loma Linda, ⁵Loma Linda University School of Medicine, Loma Linda, CA
Background/Purpose: Osteoporosis is associated with increased morbidity and mortality. There is a 60% risk of a subsequent fracture for patients who have had one fracture,…
Abstract Number: 2207 • 2019 ACR/ARP Annual Meeting
Bone Mineral Density and Microarchitecture Among Chinese Patients with Rheumatoid Arthritis
Shangyi Jin¹, Evelyn Hsieh ², Weibo Xia ³, Mengtao Li ⁴, Qian Wang ¹ and Xiaofeng Zeng ¹, ¹Department of Rheumatology, Key Laboratory of Rheumatology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, People’s Republic of China, Beijing, Beijing, China (People's Republic), ²Section of Rheumatology, Yale School of Medicine, NewHaven, CT, ³Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, Beijing, China (People's Republic), ⁴Dept. of Rheumatology, Peking Union Medical College Hospital (West Campus), Beijing, China, Beijing, China (People's Republic)
Background/Purpose: To evaluate alterations of bone mineral density and microarchitecture in patients with rheumatoid arthritis (RA). We also aimed to identify potential factors associated with…
Abstract Number: 2228 • 2019 ACR/ARP Annual Meeting
Rheumatoid Arthritis Disease Activity Is Associated with Low Femoral Neck Bone Mineral Density in a Diverse Cohort of Patients
Katherine Wysham¹, Jonathan Graf ², Jane Shofer ³, Dennis Black ², James Andrews ³, Dolores Shoback ² and Patricia Katz ², ¹Veterans Health Administration Puget Sound, Seattle WA, Seattle, ²University of California, San Francisco, San Francisco, CA, ³University of Washington, Seattle, WA
Background/Purpose: Rheumatoid arthritis (RA) is an independent risk factor for osteoporosis (OP) and fracture. Although several OP risk factors are well-described in RA, many mechanisms…
Abstract Number: 271 • 2019 ACR/ARP Annual Meeting
Who Prescribed Which Osteoporosis Medication to Whom
Jiannong Liu¹, Haifebg Guo ¹, Tingting Gong ¹ and Yi Peng ², ¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, MN
Background/Purpose: Several osteoporosis (OP) medicines came on the market in the past two decades, each with its own indications. However, there is no clear information…
Abstract Number: 2209 • 2019 ACR/ARP Annual Meeting
Study of Vertebral Fracture Prevalence and Scanographic Bone Attenuation Coefficient of the First Lumbar Vertebra (SBAC-L1) in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis vs. Controls
Marine Fauny¹, Eliane Albuisson ², Elodie Bauer ¹, Julia Perrier-Cornet ¹, Isabelle Chary-Valckenaere ² and Damien Loeuille ³, ¹CHRU Nancy, VANDOEUVRE, France, ²Centre Hospitalier Universitaire de Nancy, VANDOEUVRE, France, ³Rheumatology, Nancy University Hospital and and UMR 7365 CNRS-UL IMoPA, Université de Lorraine, VANDOEUVRE, France
Background/Purpose: Osteoporosis is a common disease whose prognosis can be seriously impacted by the development of fractures that lead to functional limitations and may even…
Abstract Number: 2229 • 2019 ACR/ARP Annual Meeting
Differences in Fracture Risk Assessment (FRAX) and Osteoporosis Treatment Cutoffs with and Without Bone Mineral Density Are Greater in Anti-Cyclic Citrullinated Peptide Positive Rheumatoid Arthritis
Katherine Wysham¹, Jonathan Graf ², Mary Margaretten ², Laura Trupin ², James Andrews ³, Dolores Shoback ² and Patricia Katz ², ¹Veterans Health Administration Puget Sound, Seattle WA, Seattle, ²University of California, San Francisco, San Francisco, CA, ³University of Washington, Seattle, WA
Background/Purpose: FRAX (Fracture Risk Assessment Tool) is the most commonly used tool to estimate 10-year fracture risk. FRAX estimates are performed with and without bone…
Abstract Number: 311 • 2019 ACR/ARP Annual Meeting
Documenting Bone Health for Veterans with Rheumatoid Arthritis in an Outpatient Academic Clinic: A Multiphase Quality Improvement Project
Melissa DeFoe¹, Rabih Nayfe ², Una Makris ³, Rashmi Arora ³ and Swathi Reddy ³, ¹VA North Texas Health Care System, Dallas, TX, ²University of Texas Southwestern Medical Center, Dallas, TX, ³University of Texas Southwestern Medical Center and the VA North Texas Health Care System, Dallas, TX
Background/Purpose: Rheumatoid Arthritis (RA) is associated with an increased risk of osteopenia and osteoporosis, which may result in fragility fractures and significant cost and morbidity. …
Abstract Number: 2210 • 2019 ACR/ARP Annual Meeting
Relationship Between Structural Spine Involvement and the Scanographic Bone Attenuation Coefficient of L1 in a Population of 73 Patients with Ankylosing Spondylitis
Marine Fauny¹, Frank VERHOEVEN ², Edem Allado ¹, Eliane Albuisson ³, Caroline Morizot ¹, Astrid Pinzano-Watrin ⁴, Isabelle Chary-Valckenaere ³ and Damien Loeuille ⁵, ¹CHRU Nancy, VANDOEUVRE, France, ²CHU Besancon, BESANCON, France, ³Centre Hospitalier Universitaire de Nancy, VANDOEUVRE, France, ⁴IMoPA. UMR 7365 CNRS, Vandoeuvre, France, ⁵Rheumatology, Nancy University Hospital and and UMR 7365 CNRS-UL IMoPA, Université de Lorraine, VANDOEUVRE, France
Background/Purpose: Thoracic and/or thoraco-abdomino-pelvic (TAP) Computed Tomography (CT) may be performed during the follow up of patients with ankylosing spondylitis (AS) and are able to…
Abstract Number: 2309 • 2019 ACR/ARP Annual Meeting
Clinical Study of Peripheral Blood Lymphocyte Subsets in Patients with Rheumatoid Arthritis Complicated with Osteoporosis
Ting Cheng¹, Sheng-xiao Zhang ², Xiao-qing Liu ¹, Jia Wang ¹, Chong Gao ³ and Xiao-feng Li ¹, ¹The Second Hospital of Shanxi Medical University, Taiyuan, China (People's Republic), ²The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China (People's Republic), ³Brigham and Women’s Hospital, Harvard Medical School, Boston
Background/Purpose: Rheumatoid arthritis(RA) is an autoimmune disease mainly manifested by aggressive polyarthritis.The incidence of osteoporosis(OP) has risen and the risk of fracture has further increased…
Abstract Number: 1126 • 2019 ACR/ARP Annual Meeting
A Medical Assistant Driven Quality Improvement Intervention Increases Rates of DEXA Screening Among RA Patients
Sarah French¹, Joshua Ng ¹, Darlene Young ², Michael Evans ³, Tobias Schmelzinger ¹, Gabriela Schmajuk ⁴, Jinoos Yazdany ⁵ and Andrew Gross ¹, ¹UCSF, San Francisco, CA, ²UCSF, San Francisco, ³University of California San Francisco, San Francisco, ⁴UCSF, SFVAMC Division of Rheumatology, San Francisco, CA, ⁵UCSF Division of Rheumatology, San Francisco, CA
Background/Purpose: Rheumatoid arthritis (RA) patients are at increased risk for developing osteoporosis as compared to the general population, even after controlling for glucocorticoid use[1]. Identification…
Abstract Number: 2211 • 2019 ACR/ARP Annual Meeting
What Are the Consequences of Spinal Ankylosis on the Bone Trabecular Fragility Assessed on CT- scan in Patients with Ankylosing Spondylitis?
Marine Fauny¹, Caroline Morizot ¹, Edem Allado ¹, Frank VERHOEVEN ², Eliane Albuisson ³, Astrid Pinzano-Watrin ⁴, Isabelle Chary-Valckenaere ³ and Damien Loeuille ⁵, ¹CHRU Nancy, VANDOEUVRE, France, ²CHU Besancon, BESANCON, France, ³Centre Hospitalier Universitaire de Nancy, VANDOEUVRE, France, ⁴IMoPA. UMR 7365 CNRS, Vandoeuvre, France, ⁵Rheumatology, Nancy University Hospital and and UMR 7365 CNRS-UL IMoPA, Université de Lorraine, VANDOEUVRE, France
Background/Purpose: Computed Tomography (CT) is sometimes performed during the follow up of patients with ankylosing spondylitis (AS) to screen comorbidities or complications. Thoracic or thoraco-abdomino-pelvic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].